Key Insights

Highlights

Treatment Research

2 treatments under study, led by Oncological Followup

Related Conditions

Often studied with 13 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Unknown1
Recruiting1

Clinical Trials (2)

Showing 2 of 2 trials
NCT05500391Phase 2Recruiting

Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring

NCT06204198UnknownPrimary

Clinicopathological Features and Molecular Typing of Invasive Fibroma of Abdominal Wall

Showing all 2 trials

Research Network

Common Treatments

  • Oncological Followup1
  • No Intervention1

Active Sponsors

  • Shandong Provincial Hospital1
  • Groupement Interrégional de Recherche Clinique et d'Innovation1
  • Canceropôle Nord Ouest1
  • Centre Oscar Lambret1

Top Investigators

Related Conditions

  • Gastrointestinal Stromal Tumors1
  • Glioma1
  • Carcinosarcoma Ovarian1
  • Ovarian Germ Cell Tumor1
  • Serous Tumor Of Ovary1

Activity Timeline